Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 3740 free, full-text research articles on human participants. First 3 results:

Treatment of HER2-positive metastatic breast cancer.
 

Author(s): Sandra M Swain, Emma Clark, José Baselga

Journal: N. Engl. J. Med.. 2015 May;372(20):1964-5.

 

Last Updated: 14 May 2015

Go To URL
Metastatic embryonal carcinoma mimicking locally advanced non-small cell lung cancer.
 

Author(s): Hiroki Numanami, Daisuke Takahashi, Emiko Takahashi, Eisuke Katsuda, Seiji Kamei, Katsuya Naruse, Kenji Baba, Masayuki Haniuda, Toyoharu Yokoi, Etsuro Yamaguchi, Akihito Kubo

Journal: Intern. Med.. 2015 ;54(1):59-61.

 

A 50-year-old man with a history of smoking of 45 pack-years underwent right lower lobectomy after neoadjuvant chemoradiotherapy for locally advanced non-small cell lung cancer diagnosed on a bronchial biopsy and standard imaging examinations, including chest-abdominal contrast-enhanced ...

Last Updated: 6 Mar 2015

Go To URL
Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.
 

Author(s): H Malik, A Z Khan, D P Berry, I C Cameron, I Pope, D Sherlock, S Helmy, B Byrne, M Thompson, A Pulfer, B Davidson

Journal: Eur J Surg Oncol. 2015 Apr;41(4):499-505.

 

The high objective response rate to cetuximab along with chemotherapy in patients with colorectal liver metastases makes it an effective downsizing protocol to facilitate surgery in those with initially unresectable disease. Adoption of this strategy has been variable in the UK. A ...

Last Updated: 30 Mar 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 377 free, full-text review articles on human participants. First 3 results:

[New therapeutical strategies in metastatic hormone-dependent breast cancer].
 

Author(s): Paul Vilquin, Pascale Cohen, Thierry Maudelonde, Olivier Tredan, Isabelle Treilleux, Thomas Bachelot, Pierre-Etienne Heudel

Journal: Bull Cancer. 2015 Apr;102(4):367-80.

 

Hormone-dependent breast cancer is the first example of cancer treated by targeted therapy for more than 30 years. Blocking estrogen pathway was the first therapeutical strategy for this subtype of breast cancer, and remains the principle of current standard treatment. Despite the ...

Last Updated: 13 Apr 2015

Go To URL
Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective.
 

Author(s): Neal D Shore

Journal: Urology. 2015 Apr;85(4):717-24.

 

Radium-223 dichloride (radium-223) is an important therapeutic option for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases, and no visceral disease. The unique mechanism of action of this first-in-class alpha-emitting radiopharmaceutical ...

Last Updated: 30 Mar 2015

Go To URL
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.
 

Author(s): Edgardo Rivera, Mary Cianfrocca

Journal: Cancer Chemother. Pharmacol.. 2015 Apr;75(4):659-70.

 

Taxanes are an established option in the standard treatment paradigm for patients with metastatic breast cancer (MBC). Neuropathy is a common, dose-limiting side effect of taxane therapy that is often managed by dose reductions and delays. The severity, time to onset, and improvement ...

Last Updated: 19 Mar 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Metastatic Melanoma; Renal Cancer

 

Last Updated: 3 Apr 2015

Go to URL
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Pancreatic Cancer; Mesothelioma; Ovarian

 

Last Updated: 30 May 2015

Go to URL

Last Updated: 20 Apr 2015

Go to URL